Myovant Sciences Ltd. Principal Executive Officer David Marek's 2021 pay jumps 154% to $6.2M

Myovant Sciences Ltd. reports 2021 executive compensation

By ExecPay News

Published: July 27, 2022

Myovant Sciences Ltd. reported fiscal year 2021 executive compensation information on July 27, 2022.
In 2021, four executives at Myovant Sciences Ltd. received on average a compensation package of $4.8M, a 27% decrease compared to previous year.
Average pay of disclosed executives at Myovant Sciences Ltd.
David Marek, Principal Executive Officer, received $6.2M in total, which decreased by 39% compared to 2020. 39% of Marek's compensation, or $2.4M, was in stock awards. Marek also received $473K in non-equity incentive plan, $2.4M in option awards, $750K in salary, as well as $207K in other compensation.
Uneek Mehra, Principal Financial Officer, received a compensation package of $5.2M. 44% of the compensation package, or $2.3M, was in option awards.
Frank Karbe, Former Principal Financial and Accounting Officer, earned $4.5M in 2021, a 49% increase compared to previous year.
Lauren Merendino, Chief Commercial Officer, received $3.5M in 2021.
Myovant Sciences Ltd.'s fiscal year ends on March 31.

Related executives

David Marek

Myovant Sciences Ltd.

Principal Executive Officer

Uneek Mehra

Myovant Sciences Ltd.

Principal Financial Officer

Frank Karbe

Myovant Sciences Ltd.

Former Principal Financial and Accounting Officer

Lauren Merendino

Myovant Sciences Ltd.

Chief Commercial Officer

You may also like

Source: SEC filing on July 27, 2022.